KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Finished Goods (2016 - 2025)

Pacific Biosciences Of California has reported Finished Goods over the past 15 years, most recently at $15.7 million for Q4 2025.

  • Quarterly results put Finished Goods at $15.7 million for Q4 2025, up 11.56% from a year ago — trailing twelve months through Dec 2025 was $15.7 million (up 11.56% YoY), and the annual figure for FY2025 was $15.7 million, up 11.56%.
  • Finished Goods for Q4 2025 was $15.7 million at Pacific Biosciences Of California, down from $16.4 million in the prior quarter.
  • Over the last five years, Finished Goods for PACB hit a ceiling of $19.8 million in Q2 2023 and a floor of $3.7 million in Q2 2021.
  • Median Finished Goods over the past 5 years was $14.8 million (2025), compared with a mean of $13.0 million.
  • Biggest five-year swings in Finished Goods: tumbled 35.22% in 2021 and later skyrocketed 151.65% in 2023.
  • Pacific Biosciences Of California's Finished Goods stood at $8.0 million in 2021, then surged by 52.35% to $12.2 million in 2022, then grew by 29.28% to $15.7 million in 2023, then decreased by 10.57% to $14.1 million in 2024, then increased by 11.56% to $15.7 million in 2025.
  • The last three reported values for Finished Goods were $15.7 million (Q4 2025), $16.4 million (Q3 2025), and $14.8 million (Q2 2025) per Business Quant data.